A powerful new drug combo has yielded a major breakthrough for men battling an aggressive form of prostate cancer, researchers found in a clinical trial.

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to results of a drug treatment trial in men whose prostate cancer had returned.

Men with recurrent prostate cancer following surgery or radiation therapy may now have a new chance to live longer. A massive global trial has found that a combination of two medications, enzalutamide and leuprolide,